Vivanza Biosciences Faces Intense Selling Pressure Amid Significant Price Declines

Vivanza Biosciences Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a consecutive decline over the past four days, resulting in a total loss of 7.44% during this period. Today, the stock fell by 1.97%, underperforming the Sensex, which saw a marginal increase of 0.01%.
Over the past month, Vivanza Biosciences has recorded a staggering decline of 21.03%, while the Sensex gained 6.04%. The stock's performance has been consistently negative, with a year-to-date drop of 42.82% compared to the Sensex's slight decline of 0.67%. Notably, the stock has reached a new 52-week low of Rs. 1.99 today.

The ongoing selling pressure may be attributed to various factors, including the stock's underperformance relative to the broader market and its trading position below key moving averages across multiple timeframes. Over the last three years, Vivanza Biosciences has seen a dramatic decline of 89.45%, contrasting sharply with the Sensex's growth of 34.76%. This trend highlights the challenges faced by the microcap company in a competitive market environment.